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Abstract
Background: We investigated the relationship between fatty acid desaturase (FADS) gene polymorphisms and
insulin resistance (IR) in association with serum phospholipid polyunsaturated fatty acid (FA) composition in healthy
Korean men.
Methods: Healthy men (n = 576, 30 ~ 79 years old) were genotyped for rs174537 near FADS1 (FEN1-10154G>T),
FADS2 (rs174575C>G, rs2727270C>T), and FADS3 (rs1000778C>T) SNPs. Dietary intake, serum phospholipid FA
composition and HOMA-IR were measured.
Results: Fasting insulin and HOMA-IR were significantly higher in the rs174575G allele carriers than the CC
homozygotes, but lower in the rs2727270T allele carriers than the CC homozygotes. The proportion of linoleic
acid (18:2ω-6, LA) was higher in the minor allele carriers of FEN1-10154G>T, rs174575C>G and rs2727270C>T
than the major homozygotes, respectively. On the other hand, the proportions of dihomo-g-linolenic acid
(20:3ω-6, DGLA) and arachidonic acid (20:4ω-6, AA) in serum phospholipids were significantly lower in the
minor allele carriers of FEN1-10154 G>T carriers and rs2727270C>T than the major homozygotes respectively.
AA was also significantly lower in the rs1000778T allele carriers than the CC homozygotes. HOMA-IR positively
correlated with LA and DGLA and negatively with AA/DGLA in total subjects. Interestingly, rs174575G allele
carriers showed remarkably higher HOMA-IR than the CC homozygotes when subjects had higher proportions
of DLGA (≥1.412% in total serum phospholipid FA composition) (P for interaction = 0.009) or of AA (≥4.573%)
(P for interaction = 0.047).
Conclusion: HOMA-IR is associated with FADS gene cluster as well as with FA composition in serum phospholipids.
Additionally, HOMA-IR may be modulated by the interaction between rs174575C>G and the proportion of DGLA or
AA in serum phospholipids.
Keywords: FADS gene homeostasis model assessment-insulin resistance, linoleic acid, dihomo-γ-linolenic acid, ara-
chidonic acid
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It has been reported that fatty acid (FA) composition in
serum phospholipids as well as a high fat intake might
influence the insulin sensitivity and the progression of
obesity [1-3]. People with insulin resistance (IR) or
metabolic syndrome (MetS) had high levels of palmitic
acid (16:0, PA) and low levels of linoleic acid (18:2ω-6,
LA) in serum phospholipids [4,5]. Lopes-Alvarenga et al
[1] showed that serum triglyceride (TG) level in MetS
subjects was positively associated with saturated FAs
(SFA), but negatively with long-chain polyunsaturated
fatty acids (PUFA). According to Leeson et al [5], higher
proportions of docosahexaenoic acid (22:6ω-3, DHA) in
erythrocyte lipids were associated with the improved
endothelial function, particularly in young smokers who
had some features of the IR.
FA composition in serum lipid esters is known to
reflect the dietary FA composition during recent one or
two months [6-9]. Serum PUFA compositions are influ-
enced by both the FA metabolisms and the genetic var-
iations [10-12]. The key enzymes involved in PUFA
metabolism are the Δ5 desaturase (D5D) and Δ6 desa-
turase (D6D) which are encoded by the FA desaturase 1
(FADS1)a n dFADS2 genes located on chromosome 11
(11q12-13.1) [13-16]. This gene cluster also includes a
FADS3, another desaturase gene which shares 52 and
62% sequence of the FADS1 and FADS2 genes, respec-
tively [13], but the activity has not been fully identified
yet. Among the single nucleotide polymorphisms (SNPs)
in FADS gene cluster, rs174537 (FEN1, flapstructure
specific endonuclease) near FADS1 shows the most sig-
nificant association with FAs in a genome-wide associa-
tion study. Minor T allele homozygotes of the rs174537
(FEN1-10154G>T) are associated with lower levels of
plasma arachidonic acid (20:4ω-6, AA) and higher levels
of LDL cholesterol and total cholesterol than the major
G allele homozygotes [16].
Recently, Dupis et al. [17] and Ingelsson et al [18]
reported that FADS1 (rs174550) was strongly associated
with fasting glucose, fasting insulin, homeostasis model
assessment of IR (HOMA-IR), HOMA-beta cell function
and type 2 diabetes in Caucasian population. However,
there were no studies on the relationship between FADS
gene and IR in association with serum PUFA composi-
tion in healthy Koreans. Therefore, this present study
aimed to investigate whether FADS gene polymorphisms
are associated with IR as well as with serum phospholi-
pid FA composition in healthy Korean men.
Subjects and Methods
Study population
Study participants (men) were recruited from the Health
Service Center (HSC) in the course of a routine checkup
visit or by a newspaper announcement for health examina-
tion. Subjects were excluded if they have orthopedic lim-
itations, weight loss/gain over the previous 6 months, or
any diagnosis of vascular disease, diabetes mellitus, cancer
(clinically or by anamnesis), renal disease, liver disease,
thyroid disease, and acute or chronic inflammatory dis-
eases. None of all subjects were taking any medications
(antihypertensive, antidyslipidemic, antithrombotic and
antidiabetic drugs). Finally, 576 healthy men (aged from
30 to 79 years old) were enrolled in the study. Written
informed consent was obtained from all subjects, and the
protocol was approved by the Institute of Review Board of
Yonsei University.
Anthropometric parameters and blood collection
Body weight and height were measured unclothed and
without shoes in the morning. Body mass index (BMI)
was calculated as body weight in kilograms divided by
height in square meters (kg/m
2). Blood pressure (BP)
was obtained from the left arm of seated patients with
an automatic blood pressure monitor (TM-2654, A&D,
Tokyo, Japan) after 20 min of rest. Study subjects were
interviewed for their smoking and drinking behavior at
their visit. Smoking habit was categorized to ‘current
smoker’ and ‘non-smoker’, and drinking habit was also
categorized to ‘current drinker (current alcohol con-
sumption)’ and ‘non-drinker’.
After overnight fast, venous blood specimens were
collected in EDTA-treated and plain tubes. The tubes
were immediately placed on ice until they arrived at the
analytical laboratory (within 1-3 h). Then, the blood spe-
cimens were separated into plasma (i.e. glucose and
insulin) or serum (i.e. lipid profiles, apolipoproteins and
fatty acid compositions), and stored at -70°C until
analysis.
Genomic DNA was extracted from 5 mL whole blood
using a commercially available DNA isolation kit
(WIZARD
R Genomic DNA purification kit, Promega,
Madison, WI, USA) according to the manufacturer’s
protocol.
Genotyping of FADS gene cluster
Genomic DNA was extracted from 5 mL whole blood
using a commercially available DNA isolation kit
(WIZARD
R Genomic DNA purification kit, Promega,
Madison, WI, USA) according to the manufacturer’s
protocol. Based on the previous reports of genetic stu-
dies as well as the public databases on the FADS gene
cluster [16,19-21] and HapMap project, http://www.hap-
map.org), 8 relevant FADS single nucleotide polymorph-
isms (SNPs) were pre-screened in randomly selected
217 subjects [rs174537 (FEN1-10154G>T near FADS1),
rs174575 (FADS2), rs1000778 (FADS3), rs2727270
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rs174583 (FADS2), rs174456 (FADS3)]. Each genotyping
reaction was performed with Taqman assay (Applied
Biosystems, Foster City, CA, USA).
Serum Lipid profile, Apolipoprotein A1 and B
Fasting serum total cholesterol and TG were measured
using commercially available kits on a Hitachi 7150
Autoanalyzer (Hitachi Ltd. Tokyo, Japan). After precipi-
tation of serum chylomicron, low density lipoprotein
(LDL) and very low density lipoprotein (VLDL) with
dextran sulfate-magnesium, high density lipoprotein
cholesterol (HDL-C) left in the supernatant was mea-
sured by an enzymatic method. LDL cholesterol (LDL-
C) was estimated indirectly using the Friedewald for-
mula for subjects with serum TG concentrations <400
mg/dL (4.52 mol/L). In subjects with serum TG concen-
trations ≥400 mg/dL (4.52 mol/L), LDL-C was measured
by an enzymetic method on a Hitachi 7150 Autoanaly-
zer directly. Each sample was measured duplicate and
their average value was used for one value. If there is
big variation between the two values, the samples were
remeasured. Serum apolipoprotein (Apo) A1 and B were
determined by turbidometry at 340 nm using a specific
anti serum (Roche, Basel, Switzerland).
Glucose, Insulin and HOMA-IR
Fasting plasma glucose was measured by a glucose oxi-
dase method using the Glucose Analyzer (Beckman
Instruments, Irvine, CA, USA). Plasma Insulin was mea-
sured by radioimmuno-assays with commercial kits
from Immuno Nucleo Corporation (Stillwater, MN,
USA). Insulin resistance (IR) was calculated with the
homeostasis model assessment (HOMA) using the fol-
lowing equation: IR = {fasting insulin (μIU/ml) × fasting
glucose (mmol/l)}/22.5 [22].
Fatty acid composition in serum phospholipids
Serum phospholipid fatty acid (FA) composition was
analyzed using the modified method of Folch et al. [23]
and Lepage et al. [24] with gas chromatography (Hewlett
Packard 5890A, CA, USA). Individual FAs were calcu-
lated as a relative percentage with the elevated FAs set
at 100% using Chemstation software.
The assessment of dietary intake/physical activity level
The subjects’ usual diet information was obtained using
both a 24-hour recall method and a semi-quantitative
food frequency questionnaire (SQFFQ) of which the
validity had been previously tested [25]. We used the for-
mer to carry out analyses and the latter to check if the
data collected by 24-hour recall methods was representa-
tive of the usual dietary pattern. All subjects were given
written and verbal instructions by a registered dietitian
on completion of a 3-day (2 week days and 1 weekend)
dietary record. Dietary energy values and nutrient con-
tent from a 3-day food records were calculated using the
Computer Aided Nutritional analysis program (CAN-pro
2.0, Korean Nutrition Society, Seoul, Korea). Total energy
expenditure (TEE) (kcal/day) was calculated from activity
patterns including basal metabolic rate, physical activity
for 24 hours [26], and specific dynamic action of food.
Basal metabolic rate for each subject was calculated with
the Harris-Benedict equation [27].
Statistical analysis
Statistical analyses were performed with SPSS version
15.0 for Windows (Statistical Package for the Social
Science, SPSS Ins., Chicago, IL, USA). Hardy-Weinberg
Equilibrium (HWE) and the linkage disequilibrium (LD)
tests were examined using the Haploviewer 4.1 (Broad
Inst, MA, USA). In order to test the difference in gen-
eral characteristics and biochemical parameters (ie. lipid
profiles, glucose, insulin resistance, fatty acid composi-
tion and dietary intakes), student t-test (independent t-
test) between the two groups (major allele homozygotes
vs minor allele carriers) and one-way analysis of var-
iance (ANOVA) among the genotype groups followed
by Bonferroni correction for multiple comparisons to
reduce the rate of false positive was used. General linear
model analysis (GLM, Post hoc multiple comparison
tests) followed by Bonferroni correction for multiple
comparisons was also performed to see the differences
in IR and FA composition between genotype groups
with adjustment for confounders (i.e. age, body mass
index, cigarette smoking, alcohol drinking, blood pres-
sure, triglyceride, total energy intake and expenditure
etc.). The Pearson correlation analyses were used to
evaluate the relationship between insulin resistance
(HOMA-IR) and general or biochemical parameters
including FA composition. In addition, multiple stepwise
regression analysis was performed to see whether FADS
SNPs remain significant influent factor on HOMA-IR
together with other markers related to HOMA-IR. Fre-
quencies were tested by chi-square test. We determined
whether each variable was normally distributed before
statistical testing, and logarithmic transformation was
p e r f o r m e do ns k e w e dv a r i a b l e s .F o rd e s c r i p t i v ep u r -
poses, mean values are presented using untransformed
values. Results are expressed as means ± standard devia-
tion (S.D.) or %. A two-tailed value of P < 0.05 was con-
sidered statistically significant.
Results
General characteristics of study population and genotype
distribution of pre-screened SNPs
Table 1 presents demographic and metabolic parameters
of whole study population. All the 8 SNPs which were
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berg Equilibrium (HWE) (P > 0.05). From the Linkage
Disequilibrium (LD) test, rs174537 (FEN1-10154G>T)
and rs174575 (FADS2 rs174575C>G) were found highly
linked (D’ = 0.93; P < 0.001) even though r
2 value was
not high (r
2 = 0.14). rs174537 and rs2727270 (FADS2
rs2727270C>T) were also found highly linked (D’ =
0.99; P < 0.001) and relatively highly correlated (r
2 =
0.74). Interestingly, rs174537 was found very highly
linked with rs174576, rs174570 and rs174583 (D’ = 1.00,
r
2>0.95 for all). Based on the the result above, we rea-
lized that rs174537 is sufficient to cover the genetic
information of last three SNPs (rs174576, rs174570 and
rs174583) as a tagging SNP. In addition, rs1000778
(FADS3 rs1000778C>T) is very highly linked to
rs174456 (FADS3 rs174456T>C) (D’ =1 ,r
2 =1 ). There-
fore, we finally included 4 SNPs (FEN1-10154
rs174537G>T, FADS2 rs174575C>G, FADS2
rs2727270C>T and FADS3 1000778C>T) for further
genotyping in the whole study subjects.
Genotype distribution of four selected SNPs
The selected 4 SNPs which were genotyped in the whole
subjects satisfied the HWE (P > 0.05) (Additional file 1).
As shown in the prescreening test, rs174537 and
rs174575 were found highly linked (D’ =0 . 9 5 ;P<
0.001)e v e nt h o u g hr
2 value was not high (r
2 =0 . 1 8 ) .
rs174537 and rs2727270 were also found highly linked
(D’ = 0.98; P < 0.001) and relatively highly correlated (r
2
= 0.67). On the other hand, rs1000778 is weakly linked
to three other SNPs (rs174537: D’ = 0.21, r
2 =0 . 0 4 ;
rs174575: D’ = 0.46, r
2 =0 . 0 4 ;rs2727270: D’ = 0.13, r
2
=0 . 0 1 ). The haplotype distribution of rs174537-
rs174575-rs2727270-rs1000778 was like this: GCCC was
most highly frequent (0.528), GCCT was second-highly
frequent (0.153), TCTC was thirdly frequent (0.144) and
TCTT was fourthly frequent (0.087).
Since haplotype analysis did not provide information
beyond that revealed by each SNP (data not shown), we
presented only the results of individual SNPs. Particu-
larly, we presented the results especially by the form of
the homozygotes for a given allele and the carrier of the
alternative allele because their general and biochemical
characteristics (i.e. insulin level, HOMA-IR and FA
composition) were shown similarly with those among 3
genotype groups, furthermore the subject number of the
minor homozygotes of rs rs174575 was so small (n = 7).
Clinical and biochemical characteristics according to FEN1
-10154G>T, FADS2 rs174575C>G, FADS2 rs2727270C>T
and FADS3 rs1000778C>T
Table 2 shows clinical and biochemical characteristics of
study subjects according to the genotypes of the FEN1
-10154G>T, FADS2 rs174575C>G, FADS2
rs2727270C>T and FADS3 rs1000778C>T, respectively.
No significant genotype-associated differences were
observed for age, BMI, systolic blood pressure (SBP),
diastolic blood pressure (DBP), serum concentrations of
TG, total cholesterol (Total-C), HDL-C, LDL-C, ApoA1,
ApoB (Table 2), total energy intake, proportions of
energy intake derived from carbohydrates and fat in
each of 4 FADS SNPs (Additional file 2). Interestingly,
fasting insulin and HOMA-IR were significantly higher
in subjects having the minor G allele of FADS2
rs174575C>G than those having the major CC homozy-
gotes. On the other hand, the levels of these two mar-
kers were significantly lower in the subjects carrying the
minor T allele of FADS2 rs2727270C>T than those
Table 1 Demographic and metabolic parameters of study
population
Total
(n = 567)
Range (Min-Max)
Age (year) 48.7 ± 9.3 30.0 - 69.0
Body mass index (kg/m
2) 24.4 ± 2.7 18.2 - 35.0
Waist circumference (cm) 85.5 ± 7.3 65.0 - 127.0
Current smokers (%) 63.0
Current drinkers (%) 16.0
MetS (%) 17.8
SBP (mmHg) 123.1 ± 14.3 90.0 - 180.0
DBP (mmHg) 76.9 ± 11.0 48.0 - 120.0
TG (mg/dL) 134.8 ± 73.8 27.0 - 477.0
Total-C (mg/dL) 192.2 ± 33.3 113.0 - 306.0
HDL-C (mg/dL) 50.4 ± 13.1 21.0 - 121.0
LDL-C (mg/dL) 115.1 ± 31.5 37.8 - 227.6
NON-HDL-C (mg/dL) 141.8 ± 33.9 55.0 - 266.0
ApoA1 (mg/dL) 140.5 ± 24.6 92.0 - 238.0
ApoB (mg/dL) 87.1 ± 23.5 45.0 - 162.0
Glucose (mg/dL) 92.9 ± 10.7 60.0 - 122.0
Insulin (μIU/mL) 8.9 ± 4.3 1.6 - 44.7
HOMA-IR 2.06 ± 1.1 0.4 - 11.4
Total energy expenditure (TEE, kcal) 2337.5 ± 202.5 361.0 - 2956.3
Total calorie intake (TIC, kcal) 2424.7 ± 208.2 1631.1 - 3055.6
TEE/TCI 0.965 ± 0.05 0.15 - 1.12
% of carbohydrates 61.7 ± 1.3 57.3 - 71.0
% of protein 16.9 ± 1.3 12.2 - 21.7
% of fat 21.5 ± 1.4 17.1 - 26.6
SFA(g) 8.3 ± 5.4 0.3 - 54.5
MUFA (g) 11.6 ± 7.0 0.6 - 110.3
PUFA (g) 11.3 ± 5.4 0.3 - 33.6
Cholesterol (mg) 271.2 ± 116.3 26.1 - 809.2
Fiber (g) 10.4 ± 4.7 2.5 - 39.7
Means ± S.D. or percentage
SBP: systolic blood pressure, DBP: diastolic blood pressure, TG: triglyceride, C:
cholesterol, Apo: apolipoprotein, HOMA-IR (homeostatis model assessment-
insulin resistance): {fasting insulin (μIU/ml) × fasting glucose (mmol/l)}/22.5,
SFA: saturated fatty acid, MUFA: monounsaturated fatty acid, PUFA:
polyunsaturated fatty acid
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Page 5 of 11having major CC homozygote (Table 3). These signifi-
cant associations still maintained after adjustment for
confounders (age, BMI, cigarette smoking, alcohol con-
sumption, blood pressure, triglyceride, total energy
expenditure and total calorie intake) which were fol-
lowed by Bonferroni correction for multiple comparisons
(Table 3).
Fatty acid composition in serum phospholipids according
to FEN1 -10154G>T, FADS2 rs174575C>G, FADS2
rs2727270C>T and FADS3 rs1000778C>T
Table 3 shows the FA composition in serum phospholi-
pids according to FEN1 -10154G>T, FADS2
rs174575C>G, FADS2 rs2727270C>T and FADS3
rs1000778C>T, respectively after the adjustment for
confounders (age, BMI, cigarette smoking, alcohol con-
sumption, blood pressure, triglyceride, total energy
expenditure and total calorie intake) which were fol-
lowed by Bonferroni correction for multiple compari-
sons. The minor T allele carriers of FEN1 -10154G>T
showed the higher proportion of linoleic acid (18:2ω-6,
LA) (P = 0.002) and lower proportion of stearic acid
(18:0, SA) (P = 0.045), dihomo-g-linolenic acid (20:3ω-6,
DGLA) (P = 0.038) and arachidonic acid (20:4ω-6, AA)
(P < 0.001) in serum phospholipids than the GG homo-
zygotes. The minor G allele carriers of FADS2
rs174575C>G had the higher proportion of LA (P =
0.001) and lower proportion of SA (P = 0.009) than the
CC homozygotes. The minor T allele carriers of FADS2
rs2727270C>T showed the higher proportion of LA (P
= 0.026), and lower proportions of DGLA (P = 0.035)
and AA (P < 0.001) than the CC homozygtes. The
minor T allele carriers of FADS3 rs1000778C>T had the
lower proportion of AA (P = 0.022) than the CC homo-
zygotes. Among FA ratios which indicate FA desaturase
activity, AA/LA were lower in the subjects carrying the
minor allele of FEN1 -10154G>T, FADS2 rs174575C>G,
FADS2 rs2727270C>T and FADS3 rs1000778C>T than
the major allele homozygote, respectively. DGLA/LA
were also were lower in the subjects carrying the minor
allele of FEN1 -10154G>T, FADS2 rs2727270C>T and
FADS3 rs1000778C>T than the major allele homozy-
gote, respectively. Additionally, DGLA/LA were lower in
the subjects carrying the minor allele of FEN1
-10154G>T and FADS2 rs2727270C>T than the major
allele homozygote, respectively.
Correlation among fatty acid composition in serum
phospholipids together with HOMA-IR
Among the FA composition in serum phospholipids,
DGLA was very highly correlated with AA (r = 0.684, P
=< 0.001) and LA (r = 0.533, P =< 0.001). LA was also
highly correlated with AA (r = 0.550, P =< 0.001). In
addition, HOMA-IR positively correlated with LA (r =
0.107, P = 0.011) and DGLA (r = 0.129, P = 0.002), and
negatively with AA/DGLA (r = -0.140, P = 0.001) in
total subjects. HOMA-IR also correlated with anthropo-
metric and basic biochemical parameters such as BMI (r
= 0.339, P < 0.001), waist (r = 0.305, P < 0.001), systolic
blood pressure (r = 0.229, P < 0.001), diastolic blood
pressure (r = 0.174, P < 0.001), triglyceride (r = 0.335, P
< 0.001), total cholesterol (r = 0.083, P = 0.048), HDL-
cholesterol (r = -0.197, P < 0.001), nonHDL-cholesterol
(r = 0.154, P < 0.001), glucose (r = 0.4479, P < 0.001)
and insulin (r = 0.967, P < 0.001).
Association of FADS gene SNPs with insulin resistance
according to the proportion of FA in serum
phospholipids
Based on the correlation results between HOMA-IR and
FA compositions mentioned above, study subjects were
subdivided into two groups according to the proportion
of LA, DGLA or AA in serum phospholipids: upper
median (LA≥12.396%, DGLA≥1.412% and AA≥4.573%.
of total FA composition in serum phospholipids) and
lower median (LA < 12.396%, DGAL < 1.412% and AA
< 4.573%). Then, we investigated the interaction effect
of genetic variants and proportion of LA, DGLA or AA
on their HOMA-IR levels (Figure 1). Interestingly,
HOMA-IR was significantly higher in minor G allele
carriers of rs174575C>G than the CC homozygotes,
w h e nt h ep r o p o r t i o no fD G L Ao rA Aw e r eh i g h e rt h a n
median value (Interaction P = 0.009 and P = 0.047,
respectively). However, significant interaction effect was
neither observed with other SNPs (FEN1 -10154G>T,
FADS2 rs2727270C>T or FADS3 rs1000778C>T) nor
with LA.
Stepwise multiple regression analysis to find the major
contributors to HOMA-IR among basic parameters and
FADS gene SNPs
Stepwise multiple linear regression analysis was per-
formed to determine whether FADS gene SNPs are the
independent influencing factors on HOMA-IR. Based on
the results of Pearson correlation coefficients (between
HOMA-IR and anthropometric or basic biochemical
parameters) and those of the LD test, we put HOMA-IR
as a dependent variable, and body mass index, triglycer-
ide, blood pressure and 4 SNPs (FEN1-10154
rs174537G>T, FADS2 rs174575 C>G, FADS2
rs2727270C>T and FADS3 rs1000778C>T) as indepen-
dent variables in the multiple stepwise linear regression
model. Among the 3 SNPs, we found that FADS2
rs174575 C>G (b-coefficient ± S.E.: 0.253 ± 0.099, p <
0.001) remained as a significant predictor of HOMA-IR
together with body mass index, triglyceride and blood
pressure (R
2 = 0.435, P < 0.001). In addition, when we
put the 4 SNPs in the model by the forms of ‘the
Kim et al. Nutrition & Metabolism 2011, 8:24
http://www.nutritionandmetabolism.com/content/8/1/24
Page 6 of 11T
a
b
l
e
3
I
n
s
u
l
i
n
,
H
O
M
A
-
I
R
a
n
d
F
a
t
t
y
a
c
i
d
c
o
m
p
o
s
i
t
i
o
n
(
%
)
i
n
s
e
r
u
m
p
h
o
s
p
h
o
l
i
p
i
d
s
a
c
c
o
r
d
i
n
g
t
o
F
E
N
1
-
1
0
1
5
4
G
>
T
,
F
A
D
S
2
r
s
1
7
4
5
7
5
,
F
A
D
S
2
r
s
2
7
2
7
2
7
0
a
n
d
r
s
F
A
D
S
3
1
0
0
0
7
7
8
C
>
T
F
E
N
1
-
1
0
1
5
4
G
>
T
F
A
D
S
2
r
s
1
7
4
5
7
5
F
A
D
S
2
r
s
2
7
2
7
2
7
0
F
E
N
1
-
1
0
1
5
4
G
>
T
G
G
(
n
=
2
5
9
)
T
c
a
r
r
i
e
r
(
n
=
3
0
8
)
C
C
(
n
=
4
7
1
)
G
c
a
r
r
i
e
r
(
n
=
9
6
)
C
C
(
n
=
3
2
3
)
T
c
a
r
r
i
e
r
(
n
=
2
4
4
)
G
G
(
n
=
2
5
9
)
G
T
+
T
T
(
n
=
3
0
8
)
I
n
s
u
l
i
n
(
μ
I
U
/
m
L
)
§
9
.
1
±
4
.
2
8
.
8
±
4
.
3
8
.
7
±
3
.
8
9
.
7
±
5
.
9
*
9
.
3
±
4
.
8
8
.
4
±
3
.
3
*
8
.
6
±
3
.
6
9
.
2
±
4
.
8
H
O
M
A
-
I
R
§
2
.
1
1
±
1
.
0
4
2
.
0
3
±
1
.
1
2
2
.
0
0
±
0
.
9
6
2
.
2
8
±
1
.
5
3
*
2
.
1
7
±
1
.
2
3
1
.
9
3
±
0
.
8
3
*
1
.
9
8
±
0
.
9
1
2
.
1
5
±
1
.
2
3
T
o
t
a
l
S
F
A
5
4
.
7
2
4
±
0
.
3
4
0
5
3
.
6
9
4
±
0
.
3
3
9
*
5
4
.
3
7
4
±
0
.
2
6
5
5
3
.
1
3
9
±
0
.
5
8
3
5
4
.
4
8
7
±
0
.
3
0
5
5
3
.
7
3
9
±
0
.
3
8
9
5
4
.
0
3
9
±
5
.
3
5
9
5
4
.
2
8
8
±
6
.
1
1
7
1
2
:
0
§
0
.
3
6
7
±
0
.
0
1
4
0
.
4
1
1
±
0
.
0
1
6
0
.
3
9
2
±
0
.
0
1
2
0
.
3
8
6
±
0
.
0
2
6
0
.
3
7
7
±
0
.
0
1
3
0
.
4
1
0
±
0
.
0
1
8
0
.
3
9
4
±
0
.
2
6
4
0
.
3
8
8
±
0
.
2
4
7
1
4
:
0
§
0
.
5
9
5
±
0
.
0
1
7
0
.
6
8
3
±
0
.
0
5
6
0
.
6
5
0
±
0
.
0
3
7
0
.
6
0
4
±
0
.
0
3
1
0
.
5
9
9
±
0
.
0
1
6
0
.
7
0
0
±
0
.
0
7
0
0
.
5
9
9
±
0
.
2
5
4
0
.
6
8
5
±
1
.
0
1
9
1
6
:
0
3
2
.
7
3
6
±
0
.
3
2
5
3
2
.
2
0
6
±
0
.
2
9
8
3
2
.
5
0
9
±
0
.
2
4
7
3
2
.
1
5
2
±
0
.
4
7
4
3
2
.
6
6
6
±
0
.
2
8
3
3
2
.
1
6
1
±
0
.
3
4
8
3
2
.
4
0
3
±
4
.
9
4
5
3
2
.
4
9
3
±
5
.
5
1
4
1
8
:
0
§
1
9
.
0
6
7
±
0
.
2
0
4
1
8
.
4
8
7
±
0
.
1
9
8
*
1
8
.
8
8
6
±
0
.
1
5
6
1
8
.
0
9
2
±
0
.
3
4
8
*
*
1
8
.
8
9
2
±
0
.
1
8
6
1
8
.
5
6
6
±
0
.
2
2
3
1
8
.
6
7
6
±
3
.
1
8
1
1
8
.
8
2
6
±
3
.
6
0
4
T
o
t
a
l
M
U
F
A
1
1
.
3
5
3
±
0
.
1
3
4
1
1
.
5
1
4
±
0
.
1
4
6
1
1
.
3
5
2
±
0
.
1
0
4
1
1
.
8
7
7
±
0
.
2
9
7
*
1
1
.
4
8
3
±
0
.
1
3
4
1
1
.
3
8
5
±
0
.
1
5
1
1
1
.
5
7
4
±
2
.
4
9
1
1
1
.
3
1
1
±
2
.
2
8
2
1
6
:
1
§
0
.
6
2
8
±
0
.
0
2
8
0
.
7
3
3
±
0
.
0
4
8
0
.
6
5
0
±
0
.
0
2
5
0
.
8
5
9
±
0
.
1
1
7
0
.
6
5
6
±
0
.
0
3
2
0
.
7
2
4
±
0
.
0
5
2
0
.
6
8
1
±
0
.
7
2
1
0
.
6
8
9
±
0
.
6
5
5
1
8
:
1
ω
-
9
6
.
9
1
7
±
0
.
1
0
1
6
.
9
9
6
±
0
.
1
0
8
6
.
9
0
3
±
0
.
0
7
7
7
.
2
3
4
±
0
.
2
2
5
7
.
0
0
2
±
0
.
1
0
3
6
.
9
0
3
±
0
.
1
0
8
7
.
0
1
5
±
1
.
8
6
9
6
.
9
0
5
±
1
.
6
7
8
1
8
:
1
ω
-
7
1
.
7
2
9
±
0
.
0
2
5
1
.
7
1
2
±
0
.
0
2
7
1
.
7
1
5
±
0
.
0
2
0
1
.
7
4
4
±
0
.
0
5
0
1
.
7
3
9
±
0
.
0
2
4
1
.
6
9
4
±
0
.
0
2
9
1
.
7
5
5
±
0
.
4
3
4
1
.
6
8
5
±
0
.
4
4
5
T
o
t
a
l
P
U
F
A
2
3
.
9
7
8
±
0
.
3
7
7
2
4
.
0
4
6
±
0
.
3
4
9
2
3
.
8
6
3
±
0
.
2
7
8
2
4
.
7
6
1
±
0
.
6
4
8
2
4
.
0
7
3
±
0
.
3
4
3
2
3
.
9
3
9
±
0
.
3
8
5
2
4
.
1
3
5
±
5
.
7
0
9
2
3
.
8
9
7
±
6
.
4
5
5
T
o
t
a
l
ω
-
6
F
A
1
9
.
2
3
7
±
0
.
2
9
7
1
9
.
2
2
9
±
0
.
2
7
4
1
9
.
0
8
2
±
0
.
2
1
7
1
9
.
9
7
3
±
0
.
5
2
8
1
9
.
3
0
4
±
0
.
2
7
2
1
9
.
1
3
8
±
0
.
2
9
8
1
9
.
2
8
6
±
4
.
3
6
5
1
9
.
1
8
0
±
5
.
1
7
8
1
8
:
2
ω
-
6
1
2
.
0
6
2
±
0
.
1
8
6
1
2
.
8
5
3
±
0
.
1
8
1
*
*
1
2
.
3
0
3
±
0
.
1
3
9
1
3
.
4
1
7
±
0
.
3
5
2
*
*
1
2
.
2
4
1
±
0
.
1
7
2
1
2
.
8
2
4
±
0
.
2
0
0
*
1
2
.
3
9
4
±
2
.
7
9
4
1
2
.
5
8
7
±
3
.
4
1
0
1
8
:
3
ω
-
6
§
0
.
2
1
8
±
0
.
0
1
4
0
.
2
3
3
±
0
.
0
1
4
0
.
2
2
7
±
0
.
0
1
2
0
.
2
2
5
±
0
.
0
2
1
0
.
2
2
3
±
0
.
0
1
3
0
.
2
3
1
±
0
.
0
1
7
0
.
2
2
8
±
0
.
2
5
8
0
.
2
2
5
±
0
.
2
2
8
2
0
:
2
ω
-
6
§
0
.
8
5
6
±
0
.
1
0
4
0
.
8
8
0
±
0
.
1
0
2
0
.
8
6
4
±
0
.
0
8
2
0
.
8
9
8
±
0
.
1
6
1
0
.
8
5
5
±
0
.
0
9
4
0
.
8
8
8
±
0
.
1
1
5
0
.
8
5
5
±
1
.
7
9
0
0
.
8
8
3
±
1
.
6
8
6
2
0
:
3
ω
-
6
1
.
5
0
4
±
0
.
0
3
4
1
.
4
0
5
±
0
.
0
3
1
*
1
.
4
4
0
±
0
.
0
2
4
1
.
4
9
8
±
0
.
0
6
3
*
1
.
4
9
2
±
0
.
0
3
2
1
.
3
9
4
±
0
.
0
3
3
*
1
.
4
5
8
±
0
.
5
1
3
1
.
4
4
2
±
0
.
5
8
0
2
0
:
4
ω
-
6
5
.
0
1
6
±
0
.
1
1
2
4
.
3
2
3
±
0
.
0
9
9
*
*
*
4
.
6
9
0
±
0
.
0
8
4
4
.
3
9
1
±
0
.
1
6
2
4
.
9
0
7
±
0
.
1
0
0
4
.
2
8
5
±
0
.
1
1
1
*
*
*
4
.
8
0
6
±
1
.
8
3
4
4
.
4
7
8
±
1
.
7
4
8
*
2
2
:
4
ω
-
6
§
0
.
2
4
7
±
0
.
0
2
0
0
.
2
1
7
±
0
.
0
1
2
0
.
2
3
0
±
0
.
0
1
2
0
.
2
3
2
±
0
.
0
2
4
0
.
2
4
3
±
0
.
0
1
7
0
.
2
1
4
±
0
.
0
1
2
0
.
2
1
9
±
0
.
1
9
1
0
.
2
4
2
±
0
.
3
1
4
2
2
:
5
ω
-
6
§
0
.
1
9
0
±
0
.
0
1
3
0
.
1
9
8
±
0
.
0
1
2
0
.
1
9
1
±
0
.
0
1
0
0
.
2
0
9
±
0
.
0
2
1
0
.
1
9
8
±
0
.
0
1
2
0
.
1
9
0
±
0
.
0
1
4
0
.
1
8
2
±
0
.
1
9
4
0
.
2
0
6
±
0
.
2
2
7
T
o
t
a
l
ω
-
3
F
A
§
4
.
7
4
1
±
0
.
1
2
3
4
.
8
1
8
±
0
.
1
2
3
4
.
7
8
1
±
0
.
0
9
7
4
.
7
8
9
±
0
.
1
9
9
4
.
7
6
9
±
0
.
1
1
0
4
.
8
0
1
±
0
.
1
4
1
4
.
8
4
9
±
2
.
1
2
5
4
.
7
1
7
±
2
.
0
3
1
1
8
:
3
ω
-
3
§
0
.
1
3
5
±
0
.
0
0
6
0
.
1
6
2
±
0
.
0
2
5
0
.
1
5
3
±
0
.
0
1
7
0
.
1
3
4
±
0
.
0
0
9
0
.
1
3
4
±
0
.
0
0
5
0
.
1
7
0
±
0
.
0
3
2
0
.
1
3
5
±
0
.
0
9
6
0
.
1
6
3
±
0
.
4
6
0
2
0
:
5
ω
-
3
§
1
.
1
5
8
±
0
.
0
3
8
1
.
1
6
6
±
0
.
0
4
2
1
.
1
7
8
±
0
.
0
3
2
1
.
0
8
5
±
0
.
0
6
2
1
.
1
6
1
±
0
.
0
3
4
1
.
1
6
5
±
0
.
0
4
8
1
.
1
9
7
±
0
.
7
5
0
1
.
1
2
9
±
0
.
6
0
2
2
2
:
5
ω
-
3
§
0
.
5
1
5
±
0
.
0
1
7
0
.
5
4
6
±
0
.
0
2
1
0
.
5
2
6
±
0
.
0
1
5
0
.
5
5
8
±
0
.
0
3
6
0
.
5
2
3
±
0
.
0
1
6
0
.
5
4
4
±
0
.
0
2
4
0
.
5
3
9
±
0
.
3
3
3
0
.
5
2
5
±
0
.
3
1
2
2
2
:
6
ω
-
3
§
2
.
8
3
3
±
0
.
0
8
8
2
.
8
6
8
±
0
.
0
8
3
2
.
8
3
7
±
0
.
0
6
6
2
.
9
2
5
±
0
.
1
4
6
2
.
8
5
2
±
0
.
0
7
9
2
.
8
5
1
±
0
.
0
9
3
2
.
8
9
7
±
1
.
4
5
8
2
.
8
0
7
±
1
.
4
0
4
1
8
:
3
ω
-
6
/
1
8
:
2
ω
-
6
§
0
.
0
1
9
±
0
.
0
0
1
0
.
0
2
0
±
0
.
0
0
2
0
.
0
1
9
±
0
.
0
0
1
0
.
0
1
8
±
0
.
0
0
2
0
.
0
1
9
±
0
.
0
0
1
0
.
0
2
0
±
0
.
0
0
2
0
.
0
1
9
±
0
.
0
2
0
0
.
0
2
0
±
0
.
0
2
8
2
0
:
3
ω
-
6
/
1
8
:
2
ω
-
6
0
.
1
2
6
±
0
.
0
0
3
0
.
1
1
2
±
0
.
0
0
3
*
*
0
.
1
2
0
±
0
.
0
0
2
0
.
1
1
1
±
0
.
0
0
4
0
.
1
2
3
±
0
.
0
0
2
0
.
1
1
3
±
0
.
0
0
4
*
0
.
1
1
9
±
0
.
0
4
1
0
.
1
1
8
±
0
.
0
5
9
2
0
:
3
ω
-
6
/
1
8
:
3
ω
-
6
§
1
3
.
0
6
6
±
0
.
6
7
9
1
1
.
4
6
0
±
0
.
5
4
1
1
2
.
2
0
6
±
0
.
4
6
9
1
2
.
1
3
4
±
1
.
0
5
5
1
2
.
5
2
7
±
0
.
5
8
5
1
1
.
7
5
2
±
0
.
6
2
6
1
2
.
4
8
7
±
1
0
.
0
7
4
1
1
.
9
0
7
±
1
0
.
3
2
7
2
0
:
4
ω
-
6
/
1
8
:
2
ω
-
6
0
.
4
1
9
±
0
.
0
1
0
0
.
3
3
9
±
0
.
0
0
8
*
*
*
0
.
3
8
5
±
0
.
0
0
7
0
.
3
2
7
±
0
.
0
1
0
*
*
*
0
.
4
0
4
±
0
.
0
0
8
0
.
3
3
8
±
0
.
0
1
0
*
*
*
0
.
3
9
2
±
0
.
1
5
7
0
.
3
5
9
±
0
.
1
4
7
*
*
2
0
:
4
ω
-
6
/
2
0
:
3
ω
-
6
§
3
.
5
0
9
±
0
.
1
0
2
3
.
1
9
2
±
0
.
0
6
0
*
*
3
.
3
8
3
±
0
.
0
6
5
3
.
1
1
2
±
0
.
0
9
9
3
.
4
6
2
±
0
.
0
8
5
3
.
1
7
2
±
0
.
0
6
9
*
*
3
.
3
8
7
±
1
.
0
2
0
3
.
2
8
8
±
1
.
6
1
8
*
M
e
a
n
±
S
.
D
.
§
T
e
s
t
e
d
b
y
l
o
g
-
t
r
a
n
s
f
o
r
m
e
d
,
P
e
r
f
o
r
m
e
d
b
y
g
e
n
e
r
a
l
l
i
n
e
a
r
m
o
d
e
l
a
n
a
l
y
s
i
s
(
G
L
M
,
P
o
s
t
h
o
c
m
u
l
t
i
p
l
e
c
o
m
p
a
r
i
s
o
n
t
e
s
t
s
)
w
i
t
h
a
d
j
u
s
t
m
e
n
t
f
o
r
a
g
e
,
b
o
d
y
m
a
s
s
i
n
d
e
x
,
c
i
g
a
r
e
t
t
e
s
m
o
k
i
n
g
,
a
l
c
o
h
o
l
d
r
i
n
k
i
n
g
,
b
l
o
o
d
p
r
e
s
s
u
r
e
,
t
r
i
g
l
y
c
e
r
i
d
e
,
t
o
t
a
l
e
n
e
r
g
y
i
n
t
a
k
e
a
n
d
e
x
p
e
n
d
i
t
u
r
e
,
f
o
l
l
o
w
e
d
b
y
B
o
n
f
e
r
r
o
n
i
c
o
r
r
e
c
t
i
o
n
f
o
r
m
u
l
t
i
p
l
e
c
o
m
p
a
r
i
s
o
n
.
A
d
j
u
s
t
e
d
P
-
v
a
l
u
e
:
*
P
<
0
.
0
5
,
*
*
P
<
0
.
0
1
a
n
d
*
*
*
P
<
0
.
0
0
1
c
o
m
p
a
r
e
d
w
i
t
h
m
a
j
o
r
a
l
l
e
l
e
f
o
r
e
a
c
h
g
e
n
o
t
y
p
e
Kim et al. Nutrition & Metabolism 2011, 8:24
http://www.nutritionandmetabolism.com/content/8/1/24
Page 7 of 11homozygotes for a given allele’ (major homozygotes) and
‘the carrier of the alternative allele’ (heterozygotes and
minor homozygotes), we found that FADS2
rs174575C>G (b-coefficient ± S.E.: 0.259 ± 0.110, p =
0.019) and FADS2 rs2727270C>T (b-coefficient ± S.E.:
-0.207 ± 0.083, p = 0.013) remained as significant pre-
dictors of HOMA-IR together with other variables (R
2 =
0.446, P < 0.001).
Discussion
In this present study, we found that HOMA-IR as well
as serum FA composition and FA ratios were associated
with the variants of FADS SNPs. This result is meaning-
ful because it was first reported in Korean men but
already done in Caucasians [17,18]. We also confirmed
that HOMA-IR was related to FA composition in serum
phospholipids, particularly LA, DGLA and AA/DGLA.
Interestingly, we found the interactive effect between
FADS2 rs174575 and the proportion DGLA or AA in
serum phospholipids on HOMA-IR: FADS2 rs174575G
allele carriers showed the remarkably higher HOMA-IR
levels than the major CC homozygotes, when they had a
higher proportion of DGLA (≥1.412% of total FA in
serum phospholipids) or AA (≥4.573%. of total FA com-
position in serum phospholipids) in serum
phospholipids.
So far, many studies have researched on the relation-
ship of serum phospholipid FA composition or dietary
fat with IR or metabolic disorder [1-5]. For example,
Vessby and his colleague reported that people with IR
or MetS had higher levels of palmitic acid and lower
levels of LA in serum phospholipids [4,5]. Warensjö et
al and others showed the significant positive relationship
between the metabolic disorder (ie. IR and obesity) and
the proportion of palmitoleic acid (16:1) and DGLA in
serum phospholipids FAs [1,4,10]. They also showed the
inverse association of IR with AA/DGLA which indi-
cates the D5D activity. In our study, we found that
HOMA-IR was positively associated with DGLA and
negatively with AA/DGLA. However, we additionally
found that HOMA-IR was positively related with LA,
which is different from others. It may be related to the
subject characteristics or the sources of FA. First, our
study subjects were all healthy without MetS nor obesity
Figure 1 Insulin resistance according to the proportion of dihomo-g-linolenic acid (20:3ω-6, DGLA) or arachidonic acid (20:4ω-6, AA) in
serum phospholipid and FADS gene polymorphisms. Means ± S.D. (n),
§tested by log-transformed, P for interaction was tested by multiple
logistic regression analysis after adjusting for age and body mass index. HOMA-IR: homeostasis model assessment of insulin resistance.
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Page 8 of 11[1,4,10]. In addition, LA and a-linolenic acid (18:3ω-3,
ALA) in serum phospholipids are generally known as
biomarkers of long-term essential FA intake [6-9], but
palmitoleic acid and DGLA are synthesized endogen-
ously by a sequence of desaturation and elongation reac-
tions rather than they reflect dietary intake of those FAs
[1]. It may indicate that DGLA or D5D are more rele-
vant to explain the relationship with IR or metabolic
disorder.
Recently, as examined in our study, the relationship
between FA composition in serum phospholipids and
the variants of FADS gene cluster has been studied
[13-16]. Among the SNPs in FADS gene cluster, FEN1-
10154G>T near FADS1 was reported to be most signifi-
cantly associated with plasma FA composition; the
minor T allele homozygotes of the FEN1-10154G>T are
associated with lower levels of plasma AA than the
major GG homozygotes [16]. In our study, the minor
allele carriers of FEN1 -10154G>T, rs2727270C>T and
FADS3 rs1000778C>T showed significantly lower pro-
portion of AA. Moreover, the proportions of DGLA,
DGLA/LA and AA/DGLA (D5D activity) were lower in
the minor allele carriers of FEN1 -10154G>T and
FADS2 rs2727270 SNPs. In addition, HOMA-IR levels
were lower in the FADS2 rs2727270T allele carriers
compared with the major CC homozytoges. All of these
results were still retained after the adjustment for con-
founders followed by Bonferroni’s correction for multi-
ple comparisons. According to Rodriguez et al., AA or
long-chain ω-6 PUFA were inversely associated with
fasting insulin levels which might be due to the reduced
desaturation-elongation cascade under IR condition
furthermore, this phenomenon may worsen as the
degree of IR increases [28]. Taken all together, our
results may indicate that subjects with the major homo-
zygotes had the impaired FA metabolism which may
cause the accumulation of DGLA, and in consequence
increase IR.
In addition, we found that rs2727270C>T (negative
direction) and particularly FADS2 rs174575C>G (posi-
tive direction) were significant influent factor on
HOMA-IR together with anthropometric or basic bio-
chemical parameters. On the other hand, we found
that HOMA-IR levels were higher in the FADS2
rs174575 G allele carriers compared with the major
CC homozytoges, which were different from the results
shown in FADS2 rs2727270C>T. These results were
still retained after the adjustment for confounders fol-
lowed by Bonferroni’s correction for multiple compari-
sons. Furthermore, the correlation between HOMA-IR
and serum PUFA composition were more clearly found
in major C homozygotes (data not shown). Interest-
ingly the higher HOMA-IR in FADS2 rs174575G car-
riers were more remarkable when the proportion of
DGLA or AA in serum phospholipids was higher than
median levels (interaction P =0 . 0 0 9a n dP = 0.047,
respectively). These results were also still retained after
the adjustment for confounders followed by Bonferro-
ni’s correction for multiple comparisons. Regarding
this discordant result, we can assume that FADS2
rs174575 SNP differently from other FADS SNPs may
affect the FA metabolism and that rs174575 may inter-
act with other genes, such as the nuclear receptor per-
oxisome proliferator-activated receptor-g (PPAR-g)o r
the adipocyte C1q and collagen-domain-containing
gene (ADIPOQ). PPAR-g is a transcriptional regulator
which directly interacts with the ADIPOQ promoter,
both of them are closely associated with IR, MetS and
diabetes mellitus [29-32]. It is known that PUFA acts
as ligands of PPAR-g [31], thus the pharmacologic acti-
vation with PPAR-g agonists may lead to the increased
plasma adiponectin [30,32], which may affect the glu-
cose and insulin metabolism. This part needs to be
further studied.
Our study has several limitations. First, study subjects
were all healthy Korean men; thus, the results may not
be applicable to women, other ethnic groups, or patients
with cardiometablic syndrome whose lifestyle habits or
biochemical characteristics may differ from those in our
subjects. For example, Warensjö et al demonstrated that
serum FA composition [i.e palmitoleic acid, g-linolenic
acid (18:3ω-6, GLA), DGLA and AA] and D6D activity
were different between men and women [1]. Second,
this study was performed in a cross-sectional design. It
is not suitable for assessing the time sequential associa-
tions because the exposure and outcomes are collected
a to n ep o i n ti nt i m e .T h i r d ,w en e e dt oc o n s i d e rt h e
involvement of other genetic backgrounds which are
associated in FA metabolism, for example PPAR-g and
ADIPOQ genes as mentioned above.
Despite these limitations, the present study shows that
HOMA-IR as well as serum FA composition and FA
ratios were associated with the variants of FADS SNPs.
Furthermore, it suggested that HOMA-IR may be
modulated by the interaction between the FADS genetic
variant and the proportion of FA, particularly DGLA in
serum phospholipids.
Conclusion
HOMA-IR and serum FA composition or FA ratios
were associated with the FADS SNPs. Interestingly,
FADS2 rs174575 and the proportion DGLA or AA in
serum phospholipids may interactively affect HOMA-IR
even in healthy people.
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Page 9 of 11Additional material
Additional file 1: Genotype and haplotype distribution of study
population. It included genotype and haplotype distribution of 4 SNPs
(FEN1-10154 rs174537G>T, FADS2 rs174575C>G, FADS2 rs2727270C>T and
FADS3 1000778C>T) in the whole study subjects. The selected 4 SNPs
satisfied the HWE (P > 0.05): minor T allele frequency of FEN1-10154
rs174537G>T was 0.312, minor G allele frequency of FADS2 rs174575C>G
was 0.082, minor T allele frequency of FADS2 rs2727270C>T was 0.24,
and minor T allele frequency of FADS3 1000778C>T was 0.293. This file
also included the haplotype distribution of rs174537-rs174575-rs2727270-
rs1000778: GCCC was the most highly frequent haplotype and the
nonGCCC frequency was 0.450.
Additional file 2: Macro-nutrient intake and energy expenditure of
study population according to FEN1 -10154G>T, FADS2 rs174575,
FADS2 rs2727270 and rsFADS3 1000778C>T. It included the
information of Macro-nutrient intake and energy expenditure according
to the genotypes of the FEN1 -10154G>T, FADS2 rs174575C>G, FADS2
rs2727270C>T and FADS3 rs1000778C>T, respectively. No significant
genotype-associated differences were observed for total energy intake,
proportions of energy intake derived from carbohydrates and fat in each
of 4 FADS SNPs.
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lipoprotein cholesterol; HOMA: homeostasis model assessment; HWE: Hardy
Weinberg Equilibrium; IR: insulin resistance; LA: linoleic acid; LD: Linkage
Disequilibrium; LDL: low density lipoprotein; MetS: metabolic syndrome;
MUFA: monounsaturated fatty acid; PUFA: polyunsaturated fatty acids; SBP:
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